신일제약 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 박종창, was filed 05 Sept 2025.
신일제약: what insiders have been doing
신일제약 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). The last twelve months, up to 8 November 2026, brought 1 filing signed by 1 insider.
No insider bought on the market over the period, while 1 insider filed 1 sale. The amount is not disclosed for 1 filing.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For context, the typical company on the same exchange (median of 2,657 companies) published 7 filings over the same period, against 1 filing here. Over the whole record (from 2021), the tally stands at 8 purchases and 5 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 40,000 sharesShareKRXDART:20260604000565
- 1,220 sharesShareKRXDART:20250905000039Canonical exit: 4 Dec 2025 (T+90)
- ShareKRXDART:20240605000236
- ●Executives0DART
- ShareKRXDART:20231222000217
- ShareKRXDART:20231222000191
- ShareKRXDART:20231222000210
- ShareKRXDART:20230918000311
- ShareKRXDART:20230918000317
- ShareKRXDART:20230914000380
- ShareKRXDART:20230914000381
- ShareKRXDART:20230914000385
- ShareKRXDART:20230914000379
- ShareKRXDART:20230914000383
- ShareKRXDART:20230914000378
- 3,916,531 sharesKRXDART:20230914000373Canonical exit: 12 Dec 2023 (T+90)
- 4,016,531 sharesKRXDART:20230914000370
- 294,137 sharesKRXDART:20230515000153
- ShareKRXDART:20230428000335
- ShareKRXDART:20230330001745
- ShareKRXDART:20230330001703
- ShareKRXDART:20230330001753
- ShareKRXDART:20230330001764
- ShareKRXDART:20230330001758
- ShareKRXDART:20230330001732
25 of 54 declarations
About 신일제약
신일제약 is a South Korean pharmaceutical company focused on the research and development of medications. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
